Zobrazeno 1 - 10
of 47
pro vyhledávání: ''
Autor:
Wim I. M. Verhagen, Inger L. Abma, P.J. van der Wees, R Haeren, H Schenck, Hieronymus D. Boogaarts, Edith Nobels-Janssen, E N Postma, M H den Hertog, Bert A Coert, D Nanda, Dagmar Verbaan, Ronald H. M. A. Bartels, Adriaan R E Potgieser, W A Moojen, J M C van Dijk
Publikováno v:
Journal of Neurology, 269, 5, pp. 2734-2742
Journal of Neurology, 269(5), 2734-2742. Springer
Journal of Neurology, 269, 2734-2742. SPRINGER HEIDELBERG
Journal of Neurology, 269. SPRINGER HEIDELBERG
Journal of Neurology, 269, 2734-2742
Journal of Neurology
Journal of neurology. D. Steinkopff-Verlag
Journal of Neurology, 269(5), 2734-2742. Springer
Journal of Neurology, 269, 2734-2742. SPRINGER HEIDELBERG
Journal of Neurology, 269. SPRINGER HEIDELBERG
Journal of Neurology, 269, 2734-2742
Journal of Neurology
Journal of neurology. D. Steinkopff-Verlag
Background and objectives The modified Rankin Scale (mRS) is one of the most frequently used outcome measures in trials in patients with an aneurysmal subarachnoid hemorrhage (aSAH). The assessment method of the mRS is often not clearly described in
Autor:
Suvankar Pal, Sharon Abrahams, Judith Newton, Emily Park, Siddharthan Chandran, Rachel Dakin, Arpan R Mehta, Charis Wong, Alan Carson, Emily Beswick
Publikováno v:
Beswick, E, Park, E, Wong, C, Mehta, A R, Dakin, R, Chandran, S, Newton, J, Carson, A, Abrahams, S & Pal, S 2020, ' A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis ', Journal of Neurology . https://doi.org/10.1007/s00415-020-10203-z
Journal of Neurology
Journal of Neurology
Background Up to 50% of people with amyotrophic lateral sclerosis (ALS) experience cognitive dysfunction, whilst depression and anxiety are reported in up to 44% and 33%, respectively. These symptoms impact on quality of life, and are associated with
Autor:
Leonard H. van den Berg, Marinus J.C. Eijkemans, Arianne J. de Fockert, Ruben P A van Eijk, Jaap N E Bakers, Tommy M. Bunte
Publikováno v:
Journal of Neurology
Journal of Neurology, 266(10), 2387. D. Steinkopff-Verlag
Journal of Neurology, 266(10), 2387. D. Steinkopff-Verlag
Background: The extensive heterogeneity between patients with amyotrophic lateral sclerosis (ALS) complicates the quantification of disease progression. In this study, we determine the value of remote, accelerometer-based monitoring of physical activ
Autor:
Vasiliki Orgeta, David J. Ahearn, Joanne Rodda, Lesley-Anne Carter, Christine Taylor, Sheree A McCormick, Sarah J. Smith, Tarek Abdel-Ghany, Jason Raw, Benjamin Kwapong, Monty Silverdale, Iracema Leroi, Ellen Poliakoff, Sabina Vatter
Publikováno v:
Mccormick, S, Vatter, S, Carter, L-A, Smith, S J, Ortega, V, Poliakoff, E, Silverdale, M, Raw, J, Ahearn, D J, Taylor, C, Rodda, J, Abdel-Ghany, T, Kwapong, B & Leroi, I 2019, ' Parkinson’s-adapted Cognitive Stimulation Therapy: Feasibility and acceptability in Lewy body spectrum disorders ', Journal of Neurology . https://doi.org/10.1007/s00415-019-09329-6
Journal of Neurology
Journal of Neurology
Background Drug-based therapeutic approaches for Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) are moderately effective and not always tolerated. Tailoring psychosocial approaches in PDD and DLB may offer additional support
Autor:
Caroline Giroudon, Sofia Boudour, M. Barral, Marie Viprey, Francis Turjman, Xavier Armoiry, Benjamin Gory, Gilles Aulagner, Anne-Marie Schott
Publikováno v:
Journal of Neurology
Journal of Neurology, 2018, 265 (7), pp.1511-1520. ⟨10.1007/s00415-018-8760-8⟩
Journal of Neurology, Springer Verlag, 2018, 265 (7), pp.1511-1520. ⟨10.1007/s00415-018-8760-8⟩
Journal of Neurology, 2018, 265 (7), pp.1511-1520. ⟨10.1007/s00415-018-8760-8⟩
Journal of Neurology, Springer Verlag, 2018, 265 (7), pp.1511-1520. ⟨10.1007/s00415-018-8760-8⟩
cited By 1; International audience; Background: Our objective was to review economic evaluations on stent-retriever thrombectomy (SRT) added/not added to intravenous (IV) tissue plasminogen activator (t-PA) in acute ischemic stroke (AIS) due to large
Autor:
Richard W. Orrell, David Hilton-Jones, Judith Hudson, Hanns Lochmüller, Maggie Williams, Teresinha Evangelista, Libby Wood, Michela Guglieri, Debbie Smith, Peter Lunt, Fiona Norwood, Tracey Willis, Karen Rafferty, Roberto Fernández-Torrón
Publikováno v:
Journal of Neurology
Facioscapulohumeral dystrophy (FSHD) is a rare inherited neuromuscular disease estimated to affect 1/15,000 people. Through basic research, remarkable progress has been made towards the development of targeted therapies. Patient identification, throu
Autor:
Rosa M. Tolón, Silvia Ortega-Gutiérrez, M. A. Alonso Alonso Arias, Javier Ruiz, Ismael Galve-Roperh, María Laura García-Bermejo, Carolina Ruiz Romero, María Jesús García de Yébenes, Sara Valdeolivas, Guillermo García Ribas, Eva Resel, Manuel Guzmán, Justo García de Yébenes Prous, Patricia Trigo Cubillo, Jose Luis López-Sendón Moreno, Onintza Sagredo, Juan García Caldentey
Publikováno v:
Journal of Neurology. 263:1390-1400
Huntington's disease (HD) is a neurodegenerative disease for which there is no curative treatment available. Given that the endocannabinoid system is involved in the pathogenesis of HD mouse models, stimulation of specific targets within this signali
Autor:
Ludwig Kappos, Michaela Andělová, Christoph Stippich, Michael Amann, Till Sprenger, Ernst-Wilhelm Radue, Simon Pezold, Katrin Weier, Yvonne Naegelin, Ketut Fundana, Philippe C. Cattin
Publikováno v:
Journal of Neurology. 263:1364-1374
Spinal cord (SC) atrophy is an important contributor to the development of disability in many neurological disorders including multiple sclerosis (MS). To assess the spinal cord atrophy in clinical trials and clinical practice, largely automated meth
Publikováno v:
Journal of Neurology. 262:1867-1875
Vertigo/dizziness (VD) ranks high in lifetime prevalence and clinical relevance. Nearly half of the complex VD disorders presenting at specialised units for vertigo or otoneurological disorders are not fully explained by an identifiable medical illne
Autor:
Giovambattista Capasso, Angela Marsili, Amedeo Cervo, Giorgia Puorro, Francesco Saccà, Giuseppe De Michele, Vincenzo Brescia Morra, Sirio Cocozza, Alessandro Filla, Francesco Trepiccione, Chiara Pane, Mario Quarantelli, Arturo Brunetti, Cinzia Valeria Russo, Mariafulvia de Leva
Publikováno v:
Journal of neurology
262 (2015): 149–153. doi:10.1007/s00415-014-7551-0
info:cnr-pdr/source/autori:Saccá, Francesco; Puorro, Giorgia; Brunetti, Arturo; Capasso, Giovambattista; Cervo, Amedeo; Cocozza, Sirio; de Leva, Mariafulvia; Marsili, Angela; Pane, Chiara; Quarantelli, Mario; Valeria Russo, Cinzia; Trepiccione, Francesco; De Michele, Giuseppe; Filla, Alessandro; Brescia Morra, Vincenzo/titolo:A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2/doi:10.1007%2Fs00415-014-7551-0/rivista:Journal of neurology (Print)/anno:2015/pagina_da:149/pagina_a:153/intervallo_pagine:149–153/volume:262
262 (2015): 149–153. doi:10.1007/s00415-014-7551-0
info:cnr-pdr/source/autori:Saccá, Francesco; Puorro, Giorgia; Brunetti, Arturo; Capasso, Giovambattista; Cervo, Amedeo; Cocozza, Sirio; de Leva, Mariafulvia; Marsili, Angela; Pane, Chiara; Quarantelli, Mario; Valeria Russo, Cinzia; Trepiccione, Francesco; De Michele, Giuseppe; Filla, Alessandro; Brescia Morra, Vincenzo/titolo:A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2/doi:10.1007%2Fs00415-014-7551-0/rivista:Journal of neurology (Print)/anno:2015/pagina_da:149/pagina_a:153/intervallo_pagine:149–153/volume:262
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder. Lithium is able to stimulate autophagy, and to reduce Ca+ efflux from the inositol-1,4,5-triphosphate receptor. We designed a phase II, randomized, placebo-controlled, double-bli